Update on Treatment Recommendations From the Fourth International Workshop on Waldenström's Macroglobulinemia

Waldenström macroglobulinemia (WM) is a distinct B-cell lymphoproliferative disorder characterized by lymphoplasmacytic bone marrow infiltration along with an immunoglobulin M (IgM) monoclonal gammopathy. Patients with disease-related cytopenias, bulky adenopathy or organomegaly, symptomatic hypervi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical oncology 2009-01, Vol.27 (1), p.120-126
Hauptverfasser:	ATHANASIOS DIMOPOULOS, Meletios, GERTZ, Morie A, OCIO, Enrique M, OWEN, Roger, GHOBRIAL, Irene M, SEYMOUR, John, KYLE, Robert A, TREON, Steven P, KASTRITIS, Efstathios, GARCIA-SANZ, Ramon, KIMBY, Eva K, LEBLOND, Veronique, FERMAND, Jean-Paul, MERLINI, Giampaolo, MOREL, Pierre, MORRA, Enrica
Format:	Artikel
Sprache:	eng
Schlagworte:	Alemtuzumab Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized Antibodies, Monoclonal, Murine-Derived Antibodies, Neoplasm - therapeutic use Biological and medical sciences Boronic Acids - administration & dosage Bortezomib Drug Therapy, Combination Hematopoietic Stem Cell Transplantation Humans Immunodeficiencies. Immunoglobulinopathies Immunoglobulinopathies Immunopathology Medical sciences Pyrazines - administration & dosage Rituximab Thalidomide - administration & dosage Thalidomide - analogs & derivatives Transplantation, Autologous Transplantation, Homologous Tumors Waldenstrom Macroglobulinemia - therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!